Concepedia

Maud Rijnders

MR

Statistics

Publications

5

Citations

124

H-Index

5

Active since

2020

Affiliations

Amphia Ziekenhuis(Current)

Amsterdam University Medical Centers

Erasmus MC Cancer Institute

Vrije Universiteit Amsterdam

Erasmus MC

Maud Rijnders is an author at Amphia Ziekenhuis specializing in pathology, medicine, and immunology.

ORCID

Top concepts

Publications per year

2020–2024

5

Publications

5

Comprehensive Molecular Characterization Reveals Genomic and Transcriptomic Subtypes of Metastatic Urothelial Carcinoma

J. Alberto Nakauma-González, Maud Rijnders, Job van Riet et al. · European Urology · 2022 · 45 citations · Full text

Differential quantities of immune checkpoint-expressing CD8 T cells in soft tissue sarcoma subtypes

Yarne Klaver, Maud Rijnders, Astrid A. M. Oostvogels et al. · Journal for ImmunoTherapy of Cancer · 2020 · 41 citations · Full text

, , +17

Genome‐wide aneuploidy detected by mFast‐SeqS in circulating cell‐free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer

Pauline A.J. Mendelaar, Debbie Robbrecht, Maud Rijnders et al. · Molecular Oncology · 2022 · 18 citations · Full text

, , +17

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer

Maud Rijnders, Debbie Robbrecht, Astrid A. M. Oostvogels et al. · Cancer Immunology Immunotherapy · 2022 · 10 citations · Full text

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer

Maud Rijnders, J. Alberto Nakauma-González, Debbie Robbrecht et al. · Nature Communications · 2024 · 10 citations · Full text

1–5 of 5